"MDGH is committed to developing new medicines and therapies for underserved populations, including to help reach the target for eliminating neglected diseases such as onchocerciasis and lymphatic filariasis. When we initiated our current clinical trials on onchocerciasis in Sub-Saharan Africa, we were determined to address the challenges of conducting research in remote communities and to find the best way to support study teams working with limited or no connectivity infrastructure. Our collaboration with CliniOps to provide eSource technologies with complete offline functionality in a unified platform is making it possible for the study team to recruit and engage participants even in the remotest locations. Our determination to complete our studies as efficiently as possible is significantly enabled by our use of CliniOps’s reliable clinical trial technologies. We look forward to building on our partnership with CliniOps, beyond our current program."